Topical imiquimod for molluscum contagiosum in T cell immunodeficiency.
Yazdani
Shahram
S
Stiehm
E Richard
ER
D000276:Adjuvants, Immunologic / Q000008:administration & dosage; D000287:Administration, Topical; D000293:Adolescent; D000634:Aminoquinolines / Q000008:administration & dosage*; D016026:Bone Marrow Transplantation; D002675:Child, Preschool; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D000077271:Imiquimod; D007153:Immunologic Deficiency Syndromes / Q000235:genetics / Q000276:immunology* / Q000628:therapy; D008976:Molluscum Contagiosum / Q000175:diagnosis / Q000188:drug therapy* / Q000276:immunology; D009894:Opportunistic Infections / Q000175:diagnosis / Q000188:drug therapy* / Q000276:immunology; D010375:Pedigree; D018570:Risk Assessment; D013601:T-Lymphocytes; D016896:Treatment Outcome
D000276:Adjuvants, Immunologic; D000634:Aminoquinolines; D000077271:Imiquimod